{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:22:52Z","timestamp":1791807772003,"version":"4.3.4"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Glob. Women\u2019s Health"],"abstract":"<jats:p>Syphilis infection during pregnancy leads to around 390,000 adverse birth outcomes each year and is an important cause of preventable stillbirth. Although benzathine penicillin G is safe and effective during pregnancy for treating maternal and fetal infection, there are frequent global shortages and limited options for people with penicillin allergy. We conducted a review of potential alternatives to penicillin for treating syphilis during pregnancy when penicillin is not available or cannot be used, including ceftriaxone, amoxicillin, doxycycline, cefixime, and linezolid. Despite some efficacy data on their use in non-pregnant adults with syphilis, limited data were available on placental transfer, pharmacokinetics and dosing, efficacy or effectiveness, and safety in pregnancy. Given its favourable preclinical reproductive toxicity data, efficacy data in non-pregnant adults with syphilis, and safety during pregnancy when used for other indications, ceftriaxone could potentially be considered as an alternative treatment for pregnant women with syphilis in cases where penicillin cannot be used, as currently recommended by the World Health Organization. However, evidence about optimal dosing, feasibility, and efficacy\/effectiveness for treating syphilis during pregnancy is needed. Several planned and ongoing clinical trials will provide additional data to inform the use of cefixime, amoxicillin, and linezolid in pregnant women with syphilis. Going forward, evaluation of new and existing medications for treating syphilis and preventing congenital syphilis should include a pregnancy investigation plan. Where possible, efforts should be made to ensure that high-quality pregnancy safety and efficacy or effectiveness data on drug candidates are generated in carefully designed studies to ensure that pregnant women and their infants are able to benefit from the full range of treatment options.<\/jats:p>","DOI":"10.3389\/fgwh.2026.1879243","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:41:53Z","timestamp":1787823713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Expanding treatment options for syphilis during pregnancy: a review of alternatives to penicillin"],"prefix":"10.3389","volume":"7","author":[{"given":"Claire L.","family":"Townsend","sequence":"first","affiliation":[{"name":"Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Mofenson","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation","place":["Washington, DC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"Department of Sexual, Reproductive, Maternal, Child, Adolescent Health and Ageing, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco P. H.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Mitj\u00e0","sequence":"additional","affiliation":[{"name":"STI and Skin NTDs Section, University Hospital Germans Trias I Pujol","place":["Badalona, Spain"]},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona","place":["Bellaterra (Cerdanyola del Vall\u00e9s), Spain"]},{"name":"Department of Infectious Diseases, Universitat de Vic-Universitat Central de Catalunya","place":["Vic, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"P\u00e9rez-Ma\u00f1\u00e1","sequence":"additional","affiliation":[{"name":"STI and Skin NTDs Section, University Hospital Germans Trias I Pujol","place":["Badalona, Spain"]},{"name":"Department of Pharmacology, Universitat Aut\u00f2noma de Barcelona","place":["Bellaterra (Cerdanyola del Vall\u00e9s), Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine J.","family":"Abrams","sequence":"additional","affiliation":[{"name":"ICAP at Columbia University and the Department of Epidemiology, Mailman School of Public Health, Columbia University","place":["New York, NY, United States"]},{"name":"Department of Pediatrics, Vagelos College of Physicians & Surgeons, Columbia University","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Delany-Moretlwe","sequence":"additional","affiliation":[{"name":"Wits RHI, University of the Witwatersrand","place":["Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Lockman","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health","place":["Boston, MA, United States"]},{"name":"Division of Infectious Diseases, Brigham & Women\u2019s Hospital","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Waitt","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, University of Liverpool","place":["Liverpool, United Kingdom"]},{"name":"Infectious Diseases Institute, Makerere University College of Health Sciences","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Miele","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie M.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Renaud","sequence":"additional","affiliation":[{"name":"Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1186\/s12889-023-15510-4","article-title":"Global, regional, and national trends of syphilis from 1990 to 2019: the 2019 global burden of disease study","volume":"23","author":"Tao","year":"2023","journal-title":"BMC Public Health"},{"key":"B3","year":"2025"},{"key":"B4","year":"2024"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.3390\/jcm14155308","article-title":"The epidemiology of syphilis worldwide in the last decade","volume":"14","author":"Rosset","year":"2025","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ajog.2022.07.041","article-title":"Syphilis in pregnancy: an ongoing public health threat","volume":"227","author":"Eppes","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2471\/BLT.12.107623","article-title":"Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis","volume":"91","author":"Gomez","year":"2013","journal-title":"Bull World Health Organ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0140-6736(15)00837-5","article-title":"Stillbirths: rates, risk factors, and acceleration towards 2030","volume":"387","author":"Lawn","year":"2016","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0211720","DOI":"10.1371\/journal.pone.0211720","article-title":"Global burden of maternal and congenital syphilis and associated adverse birth outcomes-estimates for 2016 and progress since 2012","volume":"14","author":"Korenromp","year":"2019","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJMra2202762","article-title":"Syphilis complicating pregnancy and congenital syphilis","volume":"390","author":"Stafford","year":"2024","journal-title":"N Engl J Med"},{"key":"B11","volume-title":"Updated Recommendations for the Treatment of Neisseria gonorrhoeae, Chlamydia trachomatis and Treponema pallidum (syphilis), and new Recommendations on Syphilis Testing and Partner Services","year":"2024"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1177\/09564624241280406","article-title":"BASHH UK guidelines for the management of syphilis 2024","volume":"35","author":"Kingston","year":"2024","journal-title":"Int J STD AIDS"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/AOG.0000000000005586","article-title":"Syphilis treatment among people who are pregnant in six U.S. States, 2018\u22122021","volume":"143","author":"Tannis","year":"2024","journal-title":"Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/OLQ.0000000000002108","article-title":"ASTDA position paper: alternatives to benzathine penicillin G for the treatment of syphilis during pregnancy","volume":"52","author":"Batteiger","year":"2025","journal-title":"Sex Transm Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","article-title":"2020 European guideline on the management of syphilis","volume":"35","author":"Janier","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1002473","DOI":"10.1371\/journal.pmed.1002473","article-title":"Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: an evaluation from multi-country surveys and stakeholder interviews","volume":"14","author":"Nurse-Findlay","year":"2017","journal-title":"PLoS Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/inthealth\/ihad087","article-title":"Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages","volume":"16","author":"Seghers","year":"2024","journal-title":"Int Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11904-025-00725-4","article-title":"Expanding horizons in syphilis treatment: challenges, advances, and opportunities for alternative antibiotics","volume":"22","author":"Villarreal","year":"2025","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1544","DOI":"10.1016\/S2214-109X(24)00266-3","article-title":"WHO global research priorities for sexually transmitted infections","volume":"12","author":"Gottlieb","year":"2024","journal-title":"Lancet Glob Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1473-3099(23)00693-X","article-title":"Repurposing antibiotics to treat syphilis","volume":"24","author":"Stafylis","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijantimicag.2015.10.020","article-title":"Meta-analysis of ceftriaxone compared with penicillin for the treatment of syphilis","volume":"47","author":"Liang","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"B23","year":"2025"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.3390\/jcm9082364","article-title":"Course and outcome of erythema Migrans in pregnant women","volume":"9","author":"Maraspin","year":"2020","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1067\/mob.2001.117662","article-title":"A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy","volume":"185","author":"Ramus","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0002-9378(95)90100-0","article-title":"Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. A randomized, double-blind trial","volume":"172","author":"Sanchez-Ramos","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.lanepe.2023.100737","article-title":"Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, Mycoplasma genitalium, and syphilis","volume":"34","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet Reg Health"},{"key":"B28","first-page":"37","article-title":"Biology of Treponema pallidum: correlation of functional activities with genome sequence data","volume":"3","author":"Norris","year":"2001","journal-title":"J Mol Microbiol Biotechnol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1016\/S2666-5247(23)00219-7","article-title":"Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study","volume":"4","author":"Tantalo","year":"2023","journal-title":"Lancet Microbe"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e00446","DOI":"10.1016\/j.crwh.2022.e00446","article-title":"Prevention of congenital syphilis using ceftriaxone in a woman with stevens-johnson syndrome reaction to penicillin: a case report","volume":"36","author":"Coyle","year":"2022","journal-title":"Case Rep Womens Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.olq.0000170443.70739.cd","article-title":"A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy","volume":"32","author":"Zhou","year":"2005","journal-title":"Sex Transm Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.1016\/j.ajog.2019.11.466","article-title":"Transplacental transfer of ceftriaxone in pregnant women with preterm premature rupture of membranes","volume":"222","author":"Jung","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/FTD.0000000000000950","article-title":"Understanding the pharmacokinetics of antibiotics in pregnancy: is there a role for therapeutic drug monitoring? a narrative review","volume":"44","author":"Stojanova","year":"2022","journal-title":"Ther Drug Monit"},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2710.2007.00864.x","article-title":"Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women","volume":"32","author":"Popovi\u0107","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.ajog.2023.11.221","article-title":"198 impact of pregnancy on ceftriaxone pharmacokinetics and treatment of syphilis: physiologic-based population PK modeling approach","volume":"230","author":"Heiselman","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/cid\/cix611","article-title":"A multicenter study evaluating ceftriaxone and benzathine penicillin G as treatment agents for early syphilis in Jiangsu, China","volume":"65","author":"Cao","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3201\/eid2305.161936","article-title":"Amoxicillin and ceftriaxone as treatment alternatives to penicillin for maternal syphilis","volume":"23","author":"Katanami","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-2007-994332","article-title":"Penicillin desensitization in the treatment of syphilis during pregnancy","volume":"14","author":"Chisholm","year":"1997","journal-title":"Am J Perinatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/09564624231206845","article-title":"Use of ceftriaxone as an alternative treatment method in pregnant women diagnosed with syphilis\u2014a single centre experience","volume":"35","author":"Hartmane","year":"2024","journal-title":"Int J STD AIDS"},{"key":"B40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/phar.70010","article-title":"A review of antibiotic safety in pregnancy-2025 update","volume":"45","author":"Nguyen","year":"2025","journal-title":"Pharmacotherapy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12879-020-04980-1","article-title":"Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra)","volume":"20","author":"Taylor","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12879-022-07914-1","article-title":"Antibiotic resistance of uropathogens among the community-dwelling pregnant and nonpregnant female: a step towards antibiotic stewardship","volume":"22","author":"Mohapatra","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B43","first-page":"73","article-title":"Effective cefixime treatment in pregnant women with urinary tract infection","volume":"8","author":"Al-Huseini","year":"2016","journal-title":"J Chem Pharm Res"},{"key":"B44","year":"2024"},{"key":"B45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/cid\/ciab187","article-title":"Clinical efficacy of cefixime for the treatment of early syphilis","volume":"73","author":"Stafylis","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1447-0756.2010.01246.x","article-title":"Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime","volume":"36","author":"Ozy\u00fcnc\u00fc","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1186\/s13063-020-04885-z","article-title":"Clinical trial protocol to evaluate the efficacy of cefixime in the treatment of early syphilis","volume":"21","author":"Mehta","year":"2020","journal-title":"Trials"},{"key":"B48","year":""},{"key":"B49","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1093\/jac\/dkaf268","article-title":"Cefixime versus benzathine penicillin G for the treatment of early syphilis-a randomized, controlled open label trial","volume":"80","author":"Klementov\u00e1","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"B50","article-title":"Bristol, TN, United States: USAntibiotics, LLC","year":"2025"},{"key":"B51","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/cid\/ciad278","article-title":"Combination of amoxicillin 3000\u2005mg and probenecid versus 1500\u2005mg amoxicillin monotherapy for treating syphilis in patients with human immunodeficiency virus: an open-label, randomized, controlled, non-inferiority trial","volume":"77","author":"Ando","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4102\/SAJHIVMED.v25i1.1577","article-title":"Southern African HIV clinicians society guideline for the clinical management of syphilis","volume":"25","author":"Peters","year":"2024","journal-title":"South Afr J HIV Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jiac.2019.10.016","article-title":"Case report of eight pregnant women with syphilis","volume":"26","author":"Nakasuji","year":"2020","journal-title":"J Infect Chemother"},{"key":"B54","doi-asserted-by":"publisher","first-page":"102586","DOI":"10.1016\/j.jiac.2024.12.015","article-title":"Trends in syphilis treatments and the impact of intramuscular injectable benzathine penicillin G in Japan: a descriptive study using administrative claims data from April 2016 to September 2023","volume":"31","author":"Shoji","year":"2025","journal-title":"J Infect Chemother"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3201\/eid2606.191300","article-title":"Effectiveness and tolerability of oral amoxicillin in pregnant women with active syphilis, Japan, 2010\u20132018","volume":"26","author":"Nishijima","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1128\/AAC.00119-08","article-title":"Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera","volume":"53","author":"Muller","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B57","first-page":"502","article-title":"Evaluation of the amoxicillin concentrations in amniotic fluid, placenta, umbilical cord blood and maternal serum two hours after oral administration","volume":"38","author":"Zareba-Szczudlik","year":"2017","journal-title":"Neuro Endocrinol Lett"},{"key":"B58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.toxlet.2022.12.006","article-title":"Developmental toxicity window of fetal testicular injury in offspring mice induced by prenatal amoxicillin exposure at different time, doses and courses","volume":"374","author":"Liu","year":"2023","journal-title":"Toxicol Lett"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.4317\/medoral.18807","article-title":"Prenatal effects by exposing to amoxicillin on dental enamel in wistar rats","volume":"19","author":"Gottberg","year":"2014","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"B60","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1681\/ASN.V115874","article-title":"In utero and in vitro exposure to beta-lactams impair kidney development in the rat","volume":"11","author":"Nathanson","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.clpt.6100126","article-title":"Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies","volume":"81","author":"Andrew","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"B62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/cid\/civ270","article-title":"High-dose oral amoxicillin plus probenecid is highly effective for syphilis in patients with HIV infection","volume":"61","author":"Tanizaki","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/sextrans-2020-054823","article-title":"Clinical efficacy and tolerability of 1.5\u2005g\/day oral amoxicillin therapy without probenecid for the treatment of syphilis","volume":"98","author":"Ikeuchi","year":"2022","journal-title":"Sex Transm Infect"},{"key":"B64","first-page":"103","article-title":"Beta-lactam antibiotics during pregnancy: a cross-sectional comparative study Zagreb-novi sad","volume":"16","author":"Eri\u0107","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/EDE.0b013e318258cb05","article-title":"Maternal exposure to amoxicillin and the risk of oral clefts","volume":"23","author":"Lin","year":"2012","journal-title":"Epidemiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2125.2004.02138.x","article-title":"First-trimester exposure to amoxycillin\/clavulanic acid: a prospective, controlled study","volume":"58","author":"Berkovitch","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1111\/bcp.14118","article-title":"The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy","volume":"85","author":"Daniel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B68","year":"2017"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s15010-025-02622-9","article-title":"Doxycycline safety during pregnancy: a large population-based cohort of pregnancies","volume":"53","author":"Shitrit","year":"2025","journal-title":"Infection"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e2445055","DOI":"10.1001\/jamanetworkopen.2024.45055","article-title":"First trimester tetracycline exposure and risk of Major congenital malformations","volume":"7","author":"Nakitanda","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e931","DOI":"10.1002\/hsr2.931","article-title":"Doxycycline use and adverse pregnancy or neonatal outcomes: a descriptive study using the United States food and drug administration adverse event reporting system database","volume":"5","author":"Kaundinnyayana","year":"2022","journal-title":"Health Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood\u2013time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"B73","year":"2025"},{"key":"B74","article-title":"Goa, India: Lupin Pharmaceuticals, Inc","year":"2025"},{"key":"B75","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40262-023-01226-6","article-title":"The pharmacokinetics and target attainment of antimicrobial drugs throughout pregnancy: part III non-penicillin and non-cephalosporin drugs","volume":"62","author":"Groen","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e01092","DOI":"10.1128\/AAC.01092-16","article-title":"Efficacy of doxycycline in the treatment of syphilis","volume":"61","author":"Dai","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/jac\/dkab100","article-title":"Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis","volume":"76","author":"Girometti","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1086\/500406","article-title":"Doxycycline compared with benzathine penicillin for the treatment of early syphilis","volume":"42","author":"Ghanem","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1097\/OLQ.0000000000001576","article-title":"Treatment of syphilis with doxycycline in a pregnant woman unable to be desensitized to penicillin","volume":"49","author":"Tillery","year":"2022","journal-title":"Sex Transm Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/cid\/ciz1231","article-title":"Safety of antimicrobials during pregnancy: a systematic review of antimicrobials considered for treatment and postexposure prophylaxis of plague","volume":"70","author":"Yu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-3016.2008.00978.x","article-title":"Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations","volume":"23","author":"Cooper","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0029-7844(97)00005-7","article-title":"Teratogenic study of doxycycline","volume":"89","author":"Czeizel","year":"1997","journal-title":"Obstet Gynecol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1111\/bcp.13364","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study","volume":"83","author":"Muanda","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1503\/cmaj.161020","article-title":"Use of antibiotics during pregnancy and risk of spontaneous abortion","volume":"189","author":"Muanda","year":"2017","journal-title":"Can Med Assoc J"},{"key":"B85","first-page":"315","article-title":"The role of mycoplasma among 81 consecutive pregnancies: a prospective study","volume":"25","author":"Horne","year":"1980","journal-title":"Int J Fertil"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e2023061350","DOI":"10.1542\/peds.2023-061350","article-title":"Antibiotic exposure and dental health: a systematic review","volume":"152","author":"Ravindra","year":"2023","journal-title":"Pediatrics"},{"key":"B87","article-title":"Bedminster, NJ, United States: Ascend Laboratories, LLC","year":"2025"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2003300","DOI":"10.1183\/13993003.03300-2020","article-title":"World health organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update","volume":"57","author":"Mirzayev","year":"2021","journal-title":"Eur Respir J"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1097\/INF.0000000000003069","article-title":"Outcomes of children born to pregnant women with drug-resistant Tuberculosis treated with novel drugs in khayelitsha, South Africa: a report of five patients","volume":"40","author":"Acquah","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/cid\/ciaa189","article-title":"Maternal and infant outcomes among pregnant women treated for multidrug\/rifampicin-resistant Tuberculosis in South Africa","volume":"72","author":"Loveday","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1473-3099(23)00683-7","article-title":"Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (trep-AB study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial","volume":"24","author":"Ubals","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"103281","DOI":"10.1016\/j.ebiom.2021.103281","article-title":"Efficacy of linezolid on Treponema pallidum, the syphilis agent: a preclinical study","volume":"65","author":"Haynes","year":"2021","journal-title":"EBioMedicine"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/OLQ.0000000000001860","article-title":"Safety of linezolid during pregnancy","volume":"50","author":"Navarro","year":"2023","journal-title":"Sex Transm Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/pathogens12121385","article-title":"Pharmacokinetics and safety of group A and B anti-Tuberculosis drugs used in treatment of rifampicin-resistant Tuberculosis during pregnancy and post-partum: a narrative review","volume":"12","author":"Hughes","year":"2023","journal-title":"Pathogens"},{"key":"B95","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00228-022-03446-4","article-title":"Linezolid pharmacokinetics: a systematic review for the best clinical practice","volume":"79","author":"Heidari","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"B96","volume-title":"A Multisite Pilot Study Evaluating Linezolid for Early Syphilis Treatment","author":"Stafylis","year":"2025"},{"key":"B97","author":"Conradie","year":"2025"},{"key":"B98","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/cid\/ciad767","article-title":"Pregnancy outcomes in multidrug-resistant Tuberculosis in TB-PRACTECAL","volume":"79","author":"Crocker-Buque","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/ciad445","article-title":"Pregnancy and birth outcomes in patients with multidrug-resistant Tuberculosis treated with regimens that include new and repurposed drugs","volume":"78","author":"Lotia Farrukh","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1086\/342951","article-title":"Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes","volume":"186","author":"Watson-Jones","year":"2002","journal-title":"J Infect Dis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/OLQ.0000000000002148","article-title":"Comparison of 3 treatment regimens for latent syphilis of late or unknown duration using public health surveillance data","volume":"52","author":"Hunt","year":"2025","journal-title":"Sex Transm Dis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e843","DOI":"10.1093\/cid\/ciag099","article-title":"Is 3 really what we need? Relative effectiveness of benzathine penicillin G and doxycycline treatment regimens for late or unknown duration syphilis in 6 US jurisdictions, 2016\u22122021","volume":"82","author":"Pugsley","year":"2026","journal-title":"Clin Infect Dis"},{"key":"B103","doi-asserted-by":"publisher","first-page":"SH24003","DOI":"10.1071\/SH24003","article-title":"Could late-latent syphilis be treated with a single subcutaneous infusion of long-acting penicillin?","volume":"21","author":"Hla","year":"2024","journal-title":"Sex Health"},{"key":"B104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40271-025-00764-4","article-title":"Subcutaneous infusion of benzathine penicillin G is acceptable and preferred over intramuscular injections for syphilis in western Australian sexual health clinic attendees: a mixed methods sub-study","volume":"19","author":"Walley","year":"2026","journal-title":"Patient"},{"key":"B105","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.coph.2004.04.006","article-title":"Glycopeptides in clinical development: pharmacological profile and clinical perspectives","volume":"4","author":"Bambeke","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"B106","year":"2025"},{"key":"B107","year":"2021"},{"key":"B108","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12936-022-04137-2","article-title":"Re-orienting anti-malarial drug development to better serve pregnant women","volume":"21","author":"El Gaaloul","year":"2022","journal-title":"Malar J"},{"key":"B109","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1055\/s-0037-1598070","article-title":"Improving safe and effective use of drugs in pregnancy and lactation: workshop summary","volume":"34","author":"Riley","year":"2017","journal-title":"Am J Perinatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e25916","DOI":"10.1002\/jia2.25916","article-title":"Approaches to accelerating the study of new antiretrovirals in pregnancy","volume":"25","author":"Abrams","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"B111","doi-asserted-by":"publisher","first-page":"ofag336","DOI":"10.1093\/ofid\/ofag336","article-title":"Pharmacokinetics of oral amoxicillin for the treatment of syphilis in pregnancy","volume":"13","author":"Dionne","year":"2026","journal-title":"Open Forum Infect Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e25922","DOI":"10.1002\/jia2.25922","article-title":"Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework","volume":"25","author":"Renaud","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"B113","year":"2024"},{"key":"B114","doi-asserted-by":"crossref","first-page":"S854","DOI":"10.1093\/ofid\/ofae631.1554","article-title":"Linezolid for early syphilis treatment: pilot study","volume":"12","author":"Stafylis","year":"2025","journal-title":"Open Forum Infect Dis"}],"container-title":["Frontiers in Global Women's Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2026.1879243\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:41:56Z","timestamp":1787823716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2026.1879243\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":114,"alternative-id":["10.3389\/fgwh.2026.1879243"],"URL":"https:\/\/doi.org\/10.3389\/fgwh.2026.1879243","relation":{},"ISSN":["2673-5059"],"issn-type":[{"value":"2673-5059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1879243"}}